|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| C07D 403/12 | (2013.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 413/14 | (2013.01) | ||
| C07D 403/12 | (2006.01) | ||
| C07D 401/12 | (2013.01) | ||
| C07D 413/14 | (2006.01) | ||
| C07D 403/14 | (2013.01) | ||
| C07D 403/14 | (2006.01) | ||
| C07D 409/14 | (2013.01) | ||
| C07D 409/14 | (2006.01) | ||
| C07D 417/14 | (2013.01) | ||
| C07D 417/14 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61K 31/4184 | (2006.01) |
| (11) | Patento numeris | 3630291 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18730042.1 |
| Europos patento paraiškos padavimo data | 2018-05-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2018/051447 |
| Data | 2018-05-25 |
| (87) | Numeris | WO 2018/215801 |
| Data | 2018-11-29 |
| (30) | Numeris | Data | Šalis |
| 201708502 | 2017-05-26 | GB | |
| 201806130 | 2018-04-13 | GB |
| (72) |
BELLENIE, Benjamin Richard , GB
CARTER, Michael Keith , GB
CHEUNG, Kwai Ming Jack , GB
DAVIS, Owen Alexander , GB
HOELDER, Swen , GB
LLOYD, Matthew Garth , GB
VARELA RODRÍGUEZ, Ana , GB
WOODWARD, Hannah , GB
INNOCENTI, Paolo , GB
|
| (73) |
Cancer Research Technology Limited ,
2 Redman Place, London E20 1JQ,
GB
The Institute of Cancer Research: Royal Cancer Hospital , 123 Old Brompton Road, London SW7 3RP, GB |
| (54) | BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 |
| BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6 |